40
Participants
Start Date
August 21, 2018
Primary Completion Date
February 18, 2019
Study Completion Date
February 18, 2019
PTI-428
Active
Placebo
Placebo
Mount Sinai Beth Israel, New York
Columbia University Medical Center, New York
New York Medical College, Valhalla
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Duke University Medical Center, Durham
Medical University of South Carolina, Charleston
Central Florida Pulmonary Group, Altamonte Springs
University of Alabama at Birmingham, Birmingham
Universitey of Louisville, Kosair Charities Pediatric Clinical Research Unit, Louisville
Nationwide Children's Hospital, Columbus
Akron Children's Hospital, Akron
Michigan Medicine, University of Michigan, Ann Arbor
University of Iowa, Roy J and Lucille A Carver College of Medicine, Iowa City
University of Minnesota, Minneapolis
Northwestern University, Chicago
Cystic Fibrosis Center, Children's Hospital of Illinois at OSF Saint Francis Medical Center, Peoria
Children's Mercy Hospital, Kansas City
The University of Texas Health Science Center at Tyler - Center for Clinical Research, Tyler
National Jewish Health, Denver
University of Utah, Salt Lake City
University of Arizona, Tucson
Stanford University, Stanford
Maine Medical Center, Portland
Massachusetts General Hospital, Boston
Boston Children's Hospital, Boston
Dartmouth Hitchcock Medical Center, Manchester
Proteostasis Therapeutics, Inc.
INDUSTRY